home   genetic news   bioinformatics   biotechnology   literature   journals   ethics   positions   events   sitemap
  HUM-MOLGEN -> Events -> Meetings and Conferences  

EACR Conference on Making it Personal: Cancer Precision Medicine

  April 12, 2018  
Centro Congressi Giovanni XXIII, Bergamo, Italy
05 - 07 November 2018

The conference will update you on advances in targeted and immunological therapies. It will cover issues of diagnosis and early detection and the emergence, and role of, drug-tolerant tumour fractions. There will also be a focus on rational design of combinatorial therapies and on how advances emerging from the laboratory are clinically implemented. Andrea Califano (Columbia University) and David Solit (MSKCC) will give keynote lectures.

Who should attend? Basic, translational and clinical faculty, postdocs and PhD students/trainees who are interested in currently pressing cancer-relevant questions and want to hear about the latest developments in therapies targeting cancer and immune cells. In addition, industry scientists interested in targets for novel therapies are encouraged to sign up. It is an excellent format for informal networking.

Organized by: European Association for Cancer Research
Invited Speakers: Alberto Bardelli (Italy), Andrea Califano (USA), Silvia Formenti (USA), Johanna Joyce (Switzerland), Christoph Klein (Germany), Richard Marais (UK), Jean-Christophe Marine (Belgium), Fatima Mechta-Grigoriou (France), Daniel Peeper (Netherlands), Ze'ev Ronai (Israel), Eytan Ruppin (USA), Shai Shen-Orr (Israel), Maria Soengas (Spain), David Solit (USA), Inge Marie Svane (Denmark), Itay Tirosh (Israel)
Deadline for Abstracts: 03 September 2018
Registration: Deadline: 01 October 2018
E-mail: roger.doxat-pratt@nottingham.ac.uk
home   genetic news   bioinformatics   biotechnology   literature   journals   ethics   positions   events   sitemap

Generated by meetings and positions 5.0 by Kai Garlipp
WWW: Kai Garlipp, Frank S. Zollmann.
7.0 © 1995- HUM-MOLGEN. All rights reserved. Liability, Copyright and Imprint.